US Stock MarketDetailed Quotes

CNTX Context Therapeutics

Watchlist
  • 1.3699
  • +0.0699+5.38%
Trading Apr 25 14:30 ET
21.87MMarket Cap-913P/E (TTM)

Context Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
68.49%25.07M
78.58%6.93M
52.68%6.18M
50.87%5.29M
93.63%6.67M
100.07%14.88M
25.56%3.88M
158.16%4.05M
81.03%3.51M
309.72%3.44M
Selling and administrative expenses
-6.42%7.29M
-6.11%1.63M
-13.97%1.7M
-7.99%1.83M
1.93%2.13M
114.43%7.79M
-3.38%1.74M
137.85%1.97M
229.24%1.99M
420.81%2.09M
-General and administrative expense
-6.42%7.29M
-6.11%1.63M
-13.97%1.7M
-7.99%1.83M
1.93%2.13M
114.43%7.79M
-3.38%1.74M
137.85%1.97M
229.24%1.99M
420.81%2.09M
Research and development costs
150.77%17.78M
147.19%5.3M
115.89%4.49M
128.11%3.46M
235.53%4.53M
86.36%7.09M
65.80%2.14M
180.90%2.08M
13.81%1.52M
208.04%1.35M
Operating profit
-68.49%-25.07M
-78.58%-6.93M
-52.68%-6.18M
-50.87%-5.29M
-93.63%-6.67M
-100.07%-14.88M
-25.56%-3.88M
-158.16%-4.05M
-81.03%-3.51M
-309.72%-3.44M
Net non-operating interest income expense
112.69%1.16M
-31.46%224.72K
51.08%290.44K
1,277.13%293.27K
5,963.13%355.54K
951.91%547.27K
103,983.49%327.86K
15,345.44%192.25K
6,991.91%21.3K
109.31%5.86K
Non-operating interest income
112.69%1.16M
-31.46%224.72K
51.08%290.44K
1,277.13%293.27K
5,963.13%355.54K
--547.27K
--327.86K
--192.25K
--21.3K
--5.86K
Other net income (expense)
88.93%-55.57K
-2,568.41%-61.4K
903.20%15.37K
97.55%-12.23K
316.95%2.69K
83.01%-502K
-733.70%-2.3K
-98.79%1.53K
83.83%-500K
-111.01%-1.24K
Special income (charges)
--0
--0
--0
--0
----
83.81%-500K
--0
--0
83.81%-500K
----
-Less:Other special charges
----
----
----
----
----
-83.81%500K
--0
----
-83.81%500K
----
Other non- operating income (expenses)
-2,672.95%-55.57K
-2,568.41%-61.4K
903.20%15.37K
-305,775.00%-12.23K
316.95%2.69K
-101.62%-2K
-733.70%-2.3K
-98.79%1.53K
100.09%4
-163.96%-1.24K
Income before tax
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-41.88%-14.84M
-15.04%-3.56M
-167.14%-3.85M
20.75%-3.99M
-285.44%-3.44M
Income tax
Net income
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-41.88%-14.84M
-15.04%-3.56M
-167.14%-3.85M
20.75%-3.99M
-285.44%-3.44M
Net income continuous Operations
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-41.88%-14.84M
-15.04%-3.56M
-167.14%-3.85M
20.75%-3.99M
-285.44%-3.44M
Minority interest income
Net income attributable to the parent company
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-41.88%-14.84M
-15.04%-3.56M
-167.14%-3.85M
20.75%-3.99M
-285.44%-3.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-41.88%-14.84M
-15.04%-3.56M
-167.14%-3.85M
20.75%-3.99M
-285.44%-3.44M
Basic earnings per share
-61.29%-1.5
-90.91%-0.42
-54.17%-0.37
-24.00%-0.31
-81.82%-0.4
74.80%-0.93
-13.61%-0.22
-14.39%-0.24
65.82%-0.25
-151.80%-0.22
Diluted earnings per share
-61.29%-1.5
-90.91%-0.42
-54.17%-0.37
-24.00%-0.31
-81.82%-0.4
74.80%-0.93
-13.61%-0.22
-14.39%-0.24
65.82%-0.25
-151.80%-0.22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 68.49%25.07M78.58%6.93M52.68%6.18M50.87%5.29M93.63%6.67M100.07%14.88M25.56%3.88M158.16%4.05M81.03%3.51M309.72%3.44M
Selling and administrative expenses -6.42%7.29M-6.11%1.63M-13.97%1.7M-7.99%1.83M1.93%2.13M114.43%7.79M-3.38%1.74M137.85%1.97M229.24%1.99M420.81%2.09M
-General and administrative expense -6.42%7.29M-6.11%1.63M-13.97%1.7M-7.99%1.83M1.93%2.13M114.43%7.79M-3.38%1.74M137.85%1.97M229.24%1.99M420.81%2.09M
Research and development costs 150.77%17.78M147.19%5.3M115.89%4.49M128.11%3.46M235.53%4.53M86.36%7.09M65.80%2.14M180.90%2.08M13.81%1.52M208.04%1.35M
Operating profit -68.49%-25.07M-78.58%-6.93M-52.68%-6.18M-50.87%-5.29M-93.63%-6.67M-100.07%-14.88M-25.56%-3.88M-158.16%-4.05M-81.03%-3.51M-309.72%-3.44M
Net non-operating interest income expense 112.69%1.16M-31.46%224.72K51.08%290.44K1,277.13%293.27K5,963.13%355.54K951.91%547.27K103,983.49%327.86K15,345.44%192.25K6,991.91%21.3K109.31%5.86K
Non-operating interest income 112.69%1.16M-31.46%224.72K51.08%290.44K1,277.13%293.27K5,963.13%355.54K--547.27K--327.86K--192.25K--21.3K--5.86K
Other net income (expense) 88.93%-55.57K-2,568.41%-61.4K903.20%15.37K97.55%-12.23K316.95%2.69K83.01%-502K-733.70%-2.3K-98.79%1.53K83.83%-500K-111.01%-1.24K
Special income (charges) --0--0--0--0----83.81%-500K--0--083.81%-500K----
-Less:Other special charges ---------------------83.81%500K--0-----83.81%500K----
Other non- operating income (expenses) -2,672.95%-55.57K-2,568.41%-61.4K903.20%15.37K-305,775.00%-12.23K316.95%2.69K-101.62%-2K-733.70%-2.3K-98.79%1.53K100.09%4-163.96%-1.24K
Income before tax -61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M-41.88%-14.84M-15.04%-3.56M-167.14%-3.85M20.75%-3.99M-285.44%-3.44M
Income tax
Net income -61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M-41.88%-14.84M-15.04%-3.56M-167.14%-3.85M20.75%-3.99M-285.44%-3.44M
Net income continuous Operations -61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M-41.88%-14.84M-15.04%-3.56M-167.14%-3.85M20.75%-3.99M-285.44%-3.44M
Minority interest income
Net income attributable to the parent company -61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M-41.88%-14.84M-15.04%-3.56M-167.14%-3.85M20.75%-3.99M-285.44%-3.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M-41.88%-14.84M-15.04%-3.56M-167.14%-3.85M20.75%-3.99M-285.44%-3.44M
Basic earnings per share -61.29%-1.5-90.91%-0.42-54.17%-0.37-24.00%-0.31-81.82%-0.474.80%-0.93-13.61%-0.22-14.39%-0.2465.82%-0.25-151.80%-0.22
Diluted earnings per share -61.29%-1.5-90.91%-0.42-54.17%-0.37-24.00%-0.31-81.82%-0.474.80%-0.93-13.61%-0.22-14.39%-0.2465.82%-0.25-151.80%-0.22
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg